May 03, 2018 Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
Mar 28, 2018 Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol
Mar 01, 2018 Avenue Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Corporate Highlights
Feb 06, 2018 Avenue Therapeutics to Participate in Panel on Opioid Abuse at BIO CEO & Investor Conference
Jan 02, 2018 Avenue Therapeutics Announces Dosing of First Patient in Phase 3 Safety Trial of Intravenous Tramadol for the Management of Postoperative Pain
Nov 09, 2017 Avenue Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
Sep 27, 2017 Avenue Therapeutics Announces Dosing of First Patient in Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for the Management of Postoperative Pain
Aug 15, 2017 Avenue Therapeutics Announces Appointment of Joseph Vazzano as Vice President of Finance and Corporate Controller (principal financial and accounting officer)
Aug 11, 2017 Avenue Therapeutics Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights
